News
Genprex Earlier Reported Preclinical Data For Reqorsa Immunogene Therapy And NPRL2 Gene Therapy For Lung Cancer
9 Apr 24
Biotech, News, Events, General
HC Wainwright & Co. Reiterates Buy on Genprex, Maintains $10 Price Target
4 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Genprex Expands Clinical Trial Sites For Acclaim-3 Clinical Study Of Reqorsa Therapy In Combination With Tecentriq For Small Cell Lung Cancer
3 Apr 24
Biotech, News, General
HC Wainwright & Co. Reiterates Buy on Genprex, Maintains $10 Price Target
3 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Genprex Publishes Preclinical Data With NPRL2 Gene Therapy Using Oncoprex Delivery System
2 Apr 24
Biotech, News, General
HC Wainwright & Co. Initiates Coverage On Genprex with Buy Rating, Announces Price Target of $10
25 Mar 24
News, Price Target, Initiation, Analyst Ratings
12 Health Care Stocks Moving In Tuesday's Intraday Session
19 Mar 24
Movers
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
6 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Genprex Collaborators To Present Preclinical Data On Use Of Reqorsa And On NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex Delivery System For Lung Cancers At 2024 AACR Annual Meeting
6 Mar 24
Biotech, News, Events, General
Genprex Expands Nonclinical Programs Through Sponsored Research Agreements And Material Transfer Agreements To Study TUSC2 And NPRL2 Tumor Suppressor Genes
7 Feb 24
Biotech, News, General
Dow Turns Lower; Federal Reserve Keeps Rates Unchanged
31 Jan 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
31 Jan 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Crude Oil Down 2%; Alphabet Shares Fall After Q4 Results
31 Jan 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Press releases
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
9 Apr 24
Press Releases
Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
3 Apr 24
Press Releases
Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System
2 Apr 24
Small Cap, Press Releases
Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
22 Mar 24
Offerings, Press Releases
Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
19 Mar 24
Offerings, Press Releases
Genprex Receives Notice of Patent Grant for Korean Patent Claiming Reqorsa® Immunogene Therapy with PD-1 and PD-L1 Antibodies to Treat Cancers
12 Mar 24
Small Cap, Press Releases
Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators
7 Feb 24
Press Releases
Genprex to Present at Upcoming BIO CEO & Investor Conference
6 Feb 24
Press Releases
Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa® Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
5 Feb 24
Press Releases
Genprex Announces 1-for-40 Reverse Stock Split Effective February 2, 2024
31 Jan 24
Stock Split, Press Releases